Sunday, November 8, 2009, 5:56AM ET - U.S. Markets Closed.

Steve Jobs' Health Problem: What Did Apple Know, and When Did They Know It?

Posted Jan 05, 2009 01:38pm EST by Aaron Task in Investing, Electronics, Newsmakers
Apple shares rallied Monday after CEO Steve Jobs revealed he has been diagnosed with a "hormone imbalance" that caused him to lose weight "throughout 2008," not a recurrence of cancer as many feared.

"The remedy for this nutritional problem is relatively simple and straightforward," Jobs said in a rare and remarkable statement, in which he reassured the Apple "community" that he will remain as CEO.

That's certainly good news for Jobs' fans and Apple shareholders, and hopefully Jobs' health concerns will truly be resolved. But today's announcement does not remove the controversy that has dogged the issue of Jobs' health for several months. In fact, today's news adds to speculation over whether Jobs and Apple should have and could have been more forthcoming about the CEO's health.

Consider the following when thinking about what Jobs and Apple knew, and when did they know it:

  • After Jobs' gaunt appearance at Apple's developers conference in June first set off speculation, Apple said the CEO was suffering from a "common bug." Maybe that was true but it now appears to have only been half the story, at best.
  • In July, The New York Times' Joe Nocera reported Jobs gave him "some details about his recent health problems, but only if I would agree to keep them off the record." Yet in today's statement, Jobs said this hormonal imbalance was diagnosed only "a few weeks ago"; so what, if anything, did he know and tell Nocera in July?
  • On Dec. 16, after announcing this week's MacWorld conference would be the company's last and that Jobs wouldn't deliver the keynote, Apple attributed the decision to trade shows having become "a very minor part of how Apple reaches its customers." Again, that may true but only half the story, as were reports like those of CNBC's Jim Goldman who declared last month: "Jobs' decision [to skip MacWorld] was more about politics than his pancreas."

Officially, Apple PR and executives have said repeatedly that Jobs' health is a "private matter," but the action in the stock since June suggests the CEO's health is very much a "material" event.

As with their (mis)handling of Jobs cancer and related treatment in 2003-04, Apple's action in the past seven months show the company - and the CEO - needs to do a much better job of discussing this highly controversial subject if and when it becomes a legitimate source of concern for the Apple community.

Yahoo! reserves the right to refuse, or remove any comment that does not comply with the Yahoo! Terms of Service. The submission of spam, hateful, or obscene messages may result in the termination of your Yahoo! ID.
About Tech Ticker - Send FeedbackDisclaimer. Copyright © 2007 Yahoo! Inc. All rights reserved.
Copyright/IP Policy - Terms of Service - Privacy Policy - Help
Quotes delayed, except where indicated otherwise. Delay times are 15 mins for NASDAQ, NYSE and Amex. See also delay times for other exchanges.

Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes for NASDAQ, NYSE and Amex. See also delay times for other exchanges. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. Fundamental company data provided by Capital IQ. Financials data provided by Edgar Online. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Analyst estimates data provided by Thomson Financial Network. All data provided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.